University Office (Division)

Search Results

Now showing 1 - 2 of 2

KEMTUB012-NI2, a novel potent tubulysin analog that selectively targets hypoxic cancer cells and is potentiated by cytochrome p450 reductase downregulation
(2017-05-23) Lazzari, Paolo; Spiga, Marco; Sani, Monica; Zanda, Matteo; Fleming, Ian N; University of Aberdeen.Medical Sciences; University of Aberdeen.Medical Sciences - Cardiovascular Group; University of Aberdeen.Medical Education; University of Aberdeen.Aberdeen Biomedical Imaging Centre
Improved synthesis of the hypoxia probe 5-deutero-5-fluoro-5-deoxy-azomycin arabinoside (FAZA) as a model process for tritium radiolabeling
(2013-11) Zanato, Chiara; Testa, Andrea; Zanda, Matteo; University of Aberdeen.Medical Sciences